TRIM-edicine, Inc.

TRIM-edicine, Inc. is a Columbus-based company founded to develop and commercialize protein therapeutics for regenerative medicine. The initial focus is on the use of recombinant MG53 protein in the treatment of ischemia reperfusion injury in a number of different tissues related to cardiovascular disease.


Get In Touch With Us